CIOMS V: Pragmatic Approaches to Some Current Challenges in Pharmacovigilance

Center for Drug Evaluation and Research, U.S. Food and Drug Administration

horizonal rule

CIOMS V: Pragmatic Approaches to Some
Current Challenges in Pharmacovigilance

Click here to start

Table of Contents

CIOMS V: Pragmatic Approaches to Some Current Challenges in Pharmacovigilance

COPIES OF OVERHEADS

CIOMS - Background

CIOMS V: 4 MAJOR TOPIC AREAS

CIOMS V: 4 MAJOR TOPIC AREAS

CIOMS V: 4 MAJOR TOPIC AREAS

CIOMS V: 4 MAJOR TOPIC AREAS

Clinical Evaluation of Cases

Clinical Evaluation of Cases

Clinical Evaluation of Cases

Follow Up: Proposal

Follow Up: Proposal

Follow Up: Proposal

Follow Up: Proposal

Follow Up: Proposal

LIST B (continued)

Follow Up: Proposal

LIST C (continued)

Follow Up: Proposal

Good Follow Up Practices(Contd.)- Proposal

Good Follow Up Practices(Contd.)- Proposal

Good Follow Up Practices (Contd.) - Proposal

Author: Murray M. Lumpkin, M.D.

Deputy Center Director
Center for Drug Evaluation & Research
US Food and Drug Administration

Download presentation source

Last update: July 11, 2005



	CDER Home Page \| CDER Site Info \| Contact CDER \| What's New @ CDER FDA Home Page \| Search FDA Site \| FDA A-Z Index \| Contact FDA \| Privacy \| Accessibility \| HHS Home Page FDA/Center for Drug Evaluation and Research